Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Archives of Medical Research
- Vol. 49 (8) , 620-629
Abstract
No abstract availableKeywords
Funding Information
- Fondo de Investigación en Salud (FIS/IMSS/PROT/G09/777)
This publication has 29 references indexed in Scilit:
- Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of StatinsInternational Journal of Hypertension, 2011
- No-reflow: again prevention is better than treatmentEuropean Heart Journal, 2010
- Effect of Previous Treatment With Statins on Outcome of Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2009
- Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarctionCoronary Artery Disease, 2008
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarctionEuropean Heart Journal, 2006
- Mean Platelet Volume on Admission Predicts Impaired Reperfusion and Long-Term Mortality in Acute Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionJACC, 2005
- Atorvastatin and Myocardial Reperfusion InjuryJournal of Cardiovascular Pharmacology, 2005
- Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcomeCatheterization and Cardiovascular Interventions, 2004
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003